-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-24
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1248Change
+1.50 (+0.12)%Market Cap
N/AVolume
210.00Analyst Target
N/AN/A
Verdict
Values as of: 2024-06-24
COMMON STOCK | Other |
Last Closing
USD 1248Change
+1.50 (+0.12)%Market Cap
N/AVolume
210.00Analyst Target
N/AN/A
Verdict
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
-0.01 (-1.47%) |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
N/A |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0177-OL:HK | JIANGSU EXPRESS |
-0.12 (-1.52%) |
N/A |
0240-OL:HK | BUILD KING HOLD |
+0.01 (+1.10%) |
N/A |
0243-OL:HK | QPL INT'L |
-0.01 (-8.90%) |
N/A |
0182-OL:HK | CHINA WINDPOWER |
+0.01 (+1.82%) |
N/A |
0259-OL:HK | YEEBO (INT'L H) |
-0.05 (-2.37%) |
N/A |
0187-OL:HK | JINGCHENG MAC |
+0.09 (+4.52%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
DXZ:CA | Dynamic Active U.S. Mid-C.. | 11.35 % | 0.87 % |
N/A |
CAD 0.03B |
IHF | iShares U.S. Healthcare P.. | 7.69 % | 0.43 % |
-0.03 (0.90%) |
N/A |
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
BGU:CA | Bristol Gate Concentrated.. | 4.81 % | 0.85 % |
+0.43 (+0.90%) |
CAD 0.12B |
IAI | iShares U.S. Broker-Deale.. | 4.70 % | 0.42 % |
+0.59 (+0.90%) |
N/A |
WBIF | WBI BullBear Value 3000 E.. | 4.37 % | 1.05 % |
+0.05 (+0.90%) |
N/A |
PSL | Invesco DWA Consumer Stap.. | 3.71 % | 0.60 % |
-0.14 (0.90%) |
USD 0.09B |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
DSTL | Distillate US Fundamental.. | 1.55 % | 0.00 % |
+0.41 (+0.90%) |
USD 2.05B |
FSWD:LSE | iShares Edge MSCI World M.. | 1.50 % | 0.00 % |
-0.13 (0.90%) |
N/A |
IFSW:LSE | iShares Edge MSCI World M.. | 1.50 % | 0.00 % |
+0.03 (+0.90%) |
N/A |
IBCZ:F | iShares IV Public Limited.. | 1.47 % | 0.00 % |
+0.04 (+0.90%) |
N/A |
IS07:F | iShares IV Public Limited.. | 1.47 % | 0.00 % |
+0.07 (+0.90%) |
N/A |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.66 % | 0.40 % |
+0.69 (+0.90%) |
N/A |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
+0.17 (+0.90%) |
USD 0.07B |
JKH | 0.00 % | 0.30 % |
N/A |
N/A | |
DRFU:CA | Desjardins RI USA Multifa.. | 0.00 % | 0.57 % |
N/A |
CAD 5.97M |
SPVM | Invesco S&P 500 Value wit.. | 0.00 % | 0.39 % |
+0.47 (+0.90%) |
USD 0.09B |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
XMWD:LSE | Xtrackers MSCI World Swap.. | 0.00 % | 0.00 % |
+0.60 (+0.90%) |
N/A |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
+0.65 (+0.90%) |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 15.66% | 74% | C | 77% | C+ | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 15.66% | 73% | C | 76% | C+ | ||
Trailing 12 Months | |||||||
Capital Gain | 27.22% | 83% | B | 84% | B | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 27.22% | 81% | B- | 82% | B | ||
Trailing 5 Years | |||||||
Capital Gain | 100.48% | 85% | B | 91% | A- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 100.48% | 85% | B | 89% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 15.53% | 81% | B- | 79% | B- | ||
Dividend Return | 15.53% | 78% | C+ | 77% | C+ | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 19.54% | 75% | C | 74% | C | ||
Risk Adjusted Return | 79.49% | 98% | N/A | 98% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
There is nothing we particularly dislike